Kv1.3 potassium channel blockade as an approach to insulin resistance

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.3, 2005-06, pp. : 571-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

By Wulff Heike

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1759-1765

Informa Healthcare

Access to resources Recommend Favorite

Human T-cell Kv1.3 potassium channel blockers: new strategies for immunosuppression

By Lew A. Chamberlin A.R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 905-915

Informa Healthcare

Access to resources Recommend Favorite

Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 801-806

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Discoveries Towards Kv1.5 Potassium Channel

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 339-347

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of Apoptosis in Macrophages via Kv1.3 and Kv1.5 Potassium Channels

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5394-5404

Bentham Science Publishers

Access to resources Recommend Favorite